NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.40+0.17 (+2.73%)
Close on Nov 13, 2026Market cap $29.30MP/E –Yield 0.00%
NextCure total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
NextCure's total debt was $2.64M at Jun 30, 2021. For fiscal 2020 it was $3.47M, down 30.5% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $3.47M | -30.5% |
| FY2019 | Dec 31, 2019 | $5.00M | +987.0% |
| FY2018 | Dec 31, 2018 | $460.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2021 | Jun 30, 2021 | $2.64M | -38.7% |
| Q1 FY2021 | Mar 31, 2021 | $3.06M | -35.3% |
| Q4 FY2020 | Dec 31, 2020 | $3.47M | -30.5% |
| Q3 FY2020 | Sep 30, 2020 | $3.89M | -22.2% |
| Q2 FY2020 | Jun 30, 2020 | $4.31M | -13.9% |
| Q1 FY2020 | Mar 31, 2020 | $4.72M | -5.5% |
| Q4 FY2019 | Dec 31, 2019 | $5.00M | +987.0% |
| Q3 FY2019 | Sep 30, 2019 | $5.00M | – |
| Q2 FY2019 | Jun 30, 2019 | $5.00M | – |
| Q1 FY2019 | Mar 31, 2019 | $5.00M | – |
| Q4 FY2018 | Dec 31, 2018 | $460.00K | – |
See a number that looks wrong?